Over the past several years, it has become abundantly clear that molecular events not only can be defined in prostate cancer but also can affect the treatment of patients and can have important ...

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy Herein, we highlight the strengths ...

BOSTON--(BUSINESS WIRE)--Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing ...

QUANZHOU, FUJIAN, CHINA, February 26, 2026 /EINPresswire.com/ -- The global leather and footwear sectors are currently ...